Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes (Scientific Reports, (2016), 6, 1, (26269), 10.1038/srep26269);Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Qie, Yaqing ^a   Yuan, Hengfeng ^a,b   Von Roemeling, Christina A ^a,c   Chen, Yuanxin ^a   Liu, Xiujie ^a   Shih, Kevin D ^a   Knight, Joshua A ^a   Tun, Han W ^a,d   Wharen, Robert E ^a   Jiang, Wen ^a   Kim, Betty Y S ^a  

^a MAYO CLINIC   (United States)

^b FUDAN UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; MACROGOL; NANOPARTICLE; POLYSTYRENE DERIVATIVE;

ANIMAL; C57BL MOUSE; CHEMISTRY; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; PHAGOCYTOSIS; PHENOTYPE; PHYSIOLOGY;

ANIMALS; CD47 ANTIGEN; MACROPHAGE ACTIVATION; MACROPHAGES; MICE, INBRED C57BL; NANOPARTICLES; PHAGOCYTOSIS; PHENOTYPE; POLYETHYLENE GLYCOLS; POLYSTYRENES;

EID: 84970029114     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30663     Document Type: Erratum

References (53)

1. Janeway, C. A. Jr. & Medzhitov, R. Innate Immune Recognition. Annual Review of Immunology 20, 197-216 (2002).
2. Iwasaki, A. & Medzhitov, R. Regulation of Adaptive Immunity by the Innate Immune System. Science 327, 291-295 (2010).
3. Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 122, 787-795 (2012).
4. Mantovani, A., Sica, A. & Locati, M. Macrophage polarization comes of age. Immunity 23, 344-46 (2005).
5. Mantovania, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunol. 25, 677-686 (2004).
6. Weischenfeldt, J. & Porse, B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH protocols 2008, 1-6 (2008).
7. McGarry, M. P. & Stewart, C. C. Murine eosinophil granulocytes bind the murine macrophage-monocyte specific monoclonal antibody F4/80. J. Leukoc. Biol. 50, 471-478 (1991).
8. Ho, M. K. & Springer, T. A. Mac-1 antigen: Quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J. Immunol. 128, 2281-2286 (1982).
9. Mosser, D. M. & Zhang, X. Activation of Murine Macrophages. Curr. Protocols in Immunol. 83, 14.2.1-14.2.8 (2008).
10. McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T. & Liu, W. F. Modulation of macrophage phenotype by cell shape. Proc. Natl. Acad. Sci. USA 110, 17253-17258 (2013).
11. Pelegrin, P. & Surprenant, A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates. EMBO J. 28, 2114-2127 (2009).
12. Martinez, F. O., Helming, L. & Gordon, S. Alternative Activation of Macrophages: An Immunologic Functional Perspective. Ann. Rev. Immunol. 27, 451-483 (2009).
13. Strunk, R. C., Cole, F. S., Perlmutter, D. H. & Colten, H. R. Gamma-interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes J. Biol. Chem. 260, 15280-15285 (1985).
14. Montaner, L. J. et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. J. Immunol. 162, 4606-13 (1999).
15. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan, W. C. W. Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake. J. Am. Chem. Soc. 134, 2139-2147 (2012).
16. Moreno, J. L., Mikhailenko, I., Tondravi, M. M. & Keegan, A. D. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J. Leukoc. Biol. 82, 1542-53 (2007).
17. Montaner, L. J. et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J Immunol. 162, 4606-13 (1999).
18. Murray, P. J. & Wynn, T. A. Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89, 557-563 (2011).
19. Wilson, H. M. Macrophages heterogeneity in atherosclerosis-implications for therapy. J. Cell. Mol. Med. 14, 2055-2065 (2010).
20. Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarisation. Front. Biosci. 13, 453-61 (2008).
21. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 12, 958-69 (2008).
22. Jiang, W., An, Y., Huang, Y. H. & Kim, B. Y. S. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano 9, 8689-8696 (2015).
23. Canton, J. Neculai, D. & Grinstein, S. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 13, 621-634 (2013).
24. Jaiswal, S. et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 138, 271-85 (2009).
25. Willingham, S. B. et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Nat Acad Sci USA 109, 6662-6667 (2012).
26. Brown, E. J. & Frazier, W. A. Integrin-Associated protein (CD47) and its ligands. Trends Cell Biol. 11, 130-135 (2001).
27. Tsai, R. K. & Discher, D. E. Inhibition of "self " engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J. Cell. Biol. 180, 989-1003 (2008).
28. Rodriguez, P. L. et al. Minimal "Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles. Science 339, 971-975 (2013).
29. Kong, X. N. et al. LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages. J Exp Med. 204, 2719-2731 (2007).
30. Zhang, Y., Sime, W., Juhas, M. & Sjölander, A. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. Eur J Cancer. 49, 3320-3334 (2013).
31. Kharitonenkov, A. et al. A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386, 181-186 (1997).
32. Martin-Manso, G. et al. Thrombospondin-1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. Cancer Research 68, 7090-7099 (2008).
33. Stifano, G. et al. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Research & Therapy 16, R136 (2014).
34. Grimbert, P. et al. Thrombospondin/CD47 interaction: A pathway to generate regulatory T cells-from human CD4+ CD25-T cells in response to inflammation. J Immunol. 177, 3534-3541 (2006).
35. Jiang, W., Kim, B. Y. S., Rutka, J. T. R. & Chan, W. C. W. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145-150 (2008).
36. Lunov, O. et al. Differential Uptake of Functionalized Polystyrene Nanoparticles by Human Macrophages and a Monocytic Cell Line. ACS Nano 5, 1657-1669 (2011).
37. Lartigue, L. Nanomagnetic Sensing of Blood Plasma Protein Interactions with Iron Oxide Nanoparticles: Impact on Macrophage Uptake. ACS Nano 6, 2665-2678 (2012).
38. Jones, S. W. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest. 123, 3061-3073 (2013).
39. Hoppstadter, J. et al. M2 polarization enhances silica nanoparticle uptake by macrophages. Front Pharmacol. 6, 55 (2015).
40. Agrawal, A. & Manchester, M. Differential uptake of chemically modified Cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironment. Biomacromolecules. 13, 3320-3326 (2012).
41. Zhang, M. et al. M1 Macrophages Demonstrate a Superior Phagocytic Response Against Glioblastoma Multiforme Following Anti-CD47 Treatment. J Neurosurg. 123, A541 (2015).
42. Monopoli, M. P., Aberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 7, 779-786 (2012).
43. Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 8, 772-781 (2013).
44. Schöttler, S. et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)-And poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. doi: 10.1038/nnano.2015.330 (2016).
45. Hristov, D. R. et al. Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface. Sci Rep. 5, 17040 (2015).
46. Weiskopf, K. et al. Engineered SIRPα variants as immunotherapeutic adjuvants to anti-cancer antibodies. Science 341, 6141 (2013).
47. Sosale, N. G., Spinler, K. R., Alvey, C. & Discher, D. E. Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific Marker of Self CD47, and target physical properties. Curr Opin Immunol. 35, 107-12 (2015).
48. Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T. K. & van Bruggen, R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 119, 5512-5521 (2012).
49. Hu, X. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063-70 (2012).
50. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 11, 889-896 (2010).
51. Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neuroscience 15, 300-312 (2014).
52. Han, X. et al. CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation, J. Bio. Chem. 275, 37984-37992 (2000).
53. Jiang, W., Mardyani, S., Fischer, H. & Chan, W. C. W. Design and characterization of lysine cross-linked mercapto-Acid biocompatible quantum dots. Chem. Mater. 18, 872-878 (2006).